Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20107105 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: exenatide;   Drug: rosiglitazone

Indicates status has not been verified in more than two years